Stay updated on INTRUST: Urelumab/Nivolumab Combo Clinical Trial
Sign up to get notified when there's something new on the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page.

Latest updates to the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page
- Check3 days agoChange DetectedThe page's revision tag updates from v3.5.4 to v3.5.5, indicating a minor build/version update to the page.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedAdds a new Sci Transl Med reference (2013) and marks revision v3.5.4 in the bibliography. The prior Erratum entry and author-name correction are removed.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page revision/version label was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check53 days agoChange DetectedCorrected the author name in the Sci Transl Med reference from Muhammed to Muhammad. Updated the revision from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check82 days agoChange DetectedAdded a 2026 Clin Cancer Res publication on intratumoral urelumab with nivolumab; removed the earlier Clin Cancer Res citation (online ahead of print).SummaryDifference0.1%

- Check89 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to INTRUST: Urelumab/Nivolumab Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page.